Lucid Diagnostics: Funding, Investors & Team (Aug 2026)
Lucid Diagnostics is a company that specializes in medical diagnostics for cancer prevention, intended for commercial use. The company specifically caters to patients suffering from GERD, a chronic condition also known as heartburn, who are prone to developing esophageal precancer and cancer. The EsoGuard Esophageal DNA Test is utilized by Lucid to detect such conditions, and is performed through a non-invasive in-office procedure. The EsoCheck Esophageal Cell Collection Device is capable of collecting samples, which are then used for early detection of esophageal cancer and precancer in GERD patients, making it an ideal widespread screening tool.
Lucid Diagnostics has raised $43.2M across 3 funding rounds on record, the most recent an undisclosed round of $18.0M announced in Apr 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Lucid Diagnostics Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Lucid Diagnostics Funding Rounds
Lucid Diagnostics raised $13.6M in an undisclosed round announced in Mar 2023.
1.2 years later, an undisclosed round of $11.6M was announced in May 2024.
1.9 years later, an undisclosed round of $18.0M was announced in Apr 2026.
Lucid Diagnostics Founders and Leadership Team
Contact details for the Lucid Diagnostics team: 1 of 1 has an email address on file.
Start 14-day free trial →Lucid Diagnostics Funding Compared to Other Health Care Startups
Lucid Diagnostics' latest round of $18.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lucid Diagnostics in Health Care and New York
Companies Similar to Lucid Diagnostics
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Lucid Diagnostics Funding FAQs
What does Lucid Diagnostics do?
Lucid Diagnostics is a company that specializes in medical diagnostics for cancer prevention, intended for commercial use. The company specifically caters to patients suffering from GERD, a chronic condition also known as heartburn, who are prone to developing esophageal precancer and cancer. The EsoGuard Esophageal DNA Test is utilized by Lucid to detect such conditions, and is performed through a non-invasive in-office procedure. The EsoCheck Esophageal Cell Collection Device is capable of collecting samples, which are then used for early detection of esophageal cancer and precancer in GERD patients, making it an ideal widespread screening tool.
How much funding has Lucid Diagnostics raised?
Lucid Diagnostics has raised $43.2M across 3 rounds on record. The most recent is an undisclosed round of $18.0M announced in Apr 2026.
When did Lucid Diagnostics last raise funding?
Lucid Diagnostics' most recent funding round on record is an undisclosed round of $18.0M, announced in Apr 2026.
Who founded Lucid Diagnostics?
FundedIQ lists Lishan Aklog (Founder) at Lucid Diagnostics.
Where is Lucid Diagnostics headquartered?
Lucid Diagnostics is based in New York, United States.
How many employees does Lucid Diagnostics have?
Lucid Diagnostics is in the 51-100 employee band.
How does Lucid Diagnostics' funding compare to other Health Care startups?
Lucid Diagnostics' latest round of $18.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Lucid Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lucid Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.